Medline Inc. SEC filings MDLN
Medline Inc. has 158 filings in SEC EDGAR's recent list, going back to Dec 19, 2024. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 26, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | May 21, 2026 | — |
| CORRESP | Letter to the SEC | May 20, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 21, 2026 | — |
| DRS | Filing | Apr 17, 2026 | — |
| EFFECT | Filing | Mar 4, 2026 | — |
| CORRESP | Letter to the SEC | Mar 3, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 12, 2026 | — |
| DRS | Filing | Feb 9, 2026 | — |
| CERT | Filing | Dec 17, 2025 | — |
| 8-A12B | Filing | Dec 17, 2025 | — |
| EFFECT | Filing | Dec 16, 2025 | — |
| DRS/A | Filing | Aug 15, 2025 | — |
| DRS/A | Filing | Mar 19, 2025 | — |
| DRS/A | Filing | Feb 28, 2025 | — |
| DRS/A | Filing | Jan 31, 2025 | — |
| DRS | Filing | Dec 19, 2024 | — |
Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- MDLN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Northfield, IL
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 2046386
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
- West Pharmaceutical Services Inc WST
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.